drugset / Trial / NCT01146197

Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics

NCT01146197 ↗

Phase 1/2 Completed 33 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedCrossoverOpen-labelTreatment

Summary

Gitelman syndrome is a rare renal disease where the kidneys are unable to normally retain some salts (sodium, potassium and magnesium). Main consequences of these renal leaks of salts are a tendency toward low blood pressure, hypokalemia and hypomagnesemia both contributing to cardiac and muscles symptoms.

Timeline

Start
2010-02
Primary completion
2012-12
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiloride Small molecule 10 mg —
Subject Amiloride Small molecule 20 mg —
Subject Eplerenone Unknown 50 mg —
Subject Eplerenone Unknown 150 mg —
Subject Indomethacin Small molecule 75 mg —
Background Magnesium Other / unclassified — Oral
Background Omeprazole Other / unclassified — —
Background Potassium Small molecule — Oral

Indications